Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

274
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
274
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

554
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
554
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

248
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
248
Vapor Pressure02:34

Vapor Pressure

40.6K
When a liquid vaporizes in a closed container, gas molecules cannot escape. As these gas phase molecules move randomly about, they will occasionally collide with the surface of the condensed phase, and in some cases, these collisions will result in the molecules re-entering the condensed phase. The change from the gas phase to the liquid is called condensation. When the rate of condensation becomes equal to the rate of vaporization, neither the amount of the liquid nor the amount of the vapor...
40.6K
Definition and Measurement of Pressure: Atmospheric Pressure, Barometer, and Manometer02:57

Definition and Measurement of Pressure: Atmospheric Pressure, Barometer, and Manometer

43.3K
Gas pressure is caused by force exerted by gas molecules colliding with the surfaces of objects. Although the force of each collision is very small, any surface of an appreciable area experiences a large number of collisions in a short time, which can result in high pressure.
43.3K
One-Compartment Open Model: Urinary Excretion Data and Determination of k01:11

One-Compartment Open Model: Urinary Excretion Data and Determination of k

625
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also...
625

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MeshGrow: Integrated framework for simulation-ready cardiac and vascular mesh construction from medical imaging.

JRSM cardiovascular disease·2026
Same author

Automated Centerline Extraction From Meshed Vascular Models.

International journal for numerical methods in biomedical engineering·2026
Same author

CoNFiLD-inlet: Synthetic turbulence inflow using generative latent diffusion models with neural fields.

Physical review fluids·2026
Same author

AI-powered automated model construction for patient-specific CFD simulations of aortic flows.

Science advances·2025
Same author

SeqSeg: Learning Local Segments for Automatic Vascular Model Construction.

ArXiv·2025
Same author

Conditional neural field latent diffusion model for generating spatiotemporal turbulence.

Nature communications·2024

Related Experiment Video

Updated: Jan 31, 2026

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model
08:18

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model

Published on: February 8, 2022

2.9K

Data-Augmented Modeling of Intracranial Pressure.

Jian-Xun Wang1,2, Xiao Hu3, Shawn C Shadden4

  • 1Mechanical Engineering, University of California, Berkeley, CA, USA. jwang33@nd.edu.

Annals of Biomedical Engineering
|January 5, 2019
PubMed
Summary

This study introduces a new Bayesian framework to estimate intracranial pressure (ICP) noninvasively. By combining physiological models with cerebral blood flow data, it improves ICP prediction, offering a less invasive alternative to current methods.

Keywords:
Cerebrovascular dynamicsData assimilationPatient-specific modelingTranscranial Doppler

More Related Videos

Epidural Intracranial Pressure Measurement in Rats Using a Fiber-optic Pressure Transducer
09:04

Epidural Intracranial Pressure Measurement in Rats Using a Fiber-optic Pressure Transducer

Published on: April 25, 2012

21.6K
Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

3.5K

Related Experiment Videos

Last Updated: Jan 31, 2026

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model
08:18

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model

Published on: February 8, 2022

2.9K
Epidural Intracranial Pressure Measurement in Rats Using a Fiber-optic Pressure Transducer
09:04

Epidural Intracranial Pressure Measurement in Rats Using a Fiber-optic Pressure Transducer

Published on: April 25, 2012

21.6K
Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

3.5K

Area of Science:

  • Biomedical Engineering
  • Neuroscience
  • Medical Physics

Background:

  • Intracranial pressure (ICP) monitoring is crucial for managing cerebral diseases but is invasive.
  • Current noninvasive ICP estimation methods using statistical learning have limited success due to extensive data requirements.
  • There is a need for improved, less invasive methods for ICP estimation.

Purpose of the Study:

  • To develop and validate a novel Bayesian framework for noninvasive intracranial pressure (ICP) estimation.
  • To leverage mechanistic physiological understanding to improve the utilization of noninvasive measurement data.
  • To provide a more accessible and less invasive alternative or screening tool for ICP monitoring.

Main Methods:

  • Developed a Bayesian framework integrating a multiscale model of intracranial physiology.
  • Combined the physiological model with noninvasive cerebral blood flow measurements obtained via transcranial Doppler (TCD).
  • Utilized virtual experiments with synthetic data for framework verification and analysis.

Main Results:

  • The proposed Bayesian framework successfully integrates physiological models and TCD data.
  • Virtual experiments demonstrated the framework's ability to analyze and verify ICP prediction.
  • A preliminary clinical study on two patients showed improved ICP prediction accuracy using this method.

Conclusions:

  • The developed Bayesian framework offers a promising approach for noninvasive ICP estimation.
  • Leveraging mechanistic physiology alongside noninvasive data enhances prediction accuracy.
  • This method has the potential to improve patient management for cerebral diseases by offering a less invasive ICP monitoring solution.